Key result
Physician adherence to the 2013 ACC/AHA blood cholesterol guidelines was observed in 48.3% of acute ASCVD patients, with stable LDL-C cited by 41.8% of physicians as the reason for lower intensity.
Why the study?
Although guidelines recommend statins after acute cardiovascular events, many patients remain untreated or undertreated, and the reasons for this remain unknown.
What is the rate of physician adherence to the 2013 ACC/AHA blood cholesterol guidelines for patients with acute ASCVD, and what are the reasons for non-adherence?
Observational (n=4,016)
No
What is the rate of physician adherence to the 2013 ACC/AHA blood cholesterol guidelines for patients with acute ASCVD, and what are the reasons for non-adherence?
Physician adherence to 2013 ACC/AHA cholesterol guidelines for secondary prevention remains poor (<50%), largely driven by the outdated practice of targeting specific LDL-C levels rather than prescribing recommended high-intensity statin doses.
Suboptimal adherence signals need for clinician education on statin dosing; leaves open whether targeted interventions improve uptake.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ramsaran et al. (2019) conducted an observational in Acute atherosclerotic cardiovascular disease (n=4,016). 2013 ACC/AHA blood cholesterol guidelines was evaluated on Adherence to 2013 ACC/AHA blood cholesterol guidelines. Physician adherence to the 2013 ACC/AHA blood cholesterol guidelines was observed in 48.3% of acute ASCVD patients, with stable LDL-C cited by 41.8% of physicians as the reason for lower intensity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: